Scilife, a quality management system transforming the life sciences sector, is thrilled to announce a strategic growth investment from Five Elms Capital, a leading software investment firm. Quality management ensures the continuous delivery of high-quality products and services that meet quality objectives, regulations, and customer requirements.
This partnership will allow Scilife to bolster market presence and adoption of its innovative electronic quality management system (eQMS).
Scilife, known for its dynamic Smart Quality Platform, has been instrumental in redefining quality management by integrating advanced data analytics, augmented learning, and gamification. This approach simplifies compliance and positions quality as a key driver of value creation and competitive advantage. The platform’s impact has been significant, offering clarity and efficiency in quality management processes, reducing compliance risk, and enhancing operational transparency.
Image taken from LinkedIn profile
Filip Heitbrik, CEO at Scilife, shared, “We’re excited to work with the like-minded team at Five Elms—a partner who is as committed as we are in making Smart Quality an instrumental catalyst for value creation. This approach ensures that every team member not only understands their role in upholding quality but is also equipped to contribute effectively.”
Scilife has garnered trust from hundreds of leading life sciences companies worldwide, including Novartis, Biocartis, Yusen Logistics, Polpharma, and Pendulum, among others. These organizations have leveraged Scilife to manage their quality processes effectively, empowering employees to take ownership of quality, enhancing efficiency, and ultimately improving patient outcomes. Organizations using Scilife have seen up to a 50% reduction in the total cost of quality assurance and accelerated their time to market by up to 30%.
Image taken from Five Elms Capital website
“Quality is not just a compliance requirement; it’s a strategic asset that can significantly differentiate life sciences companies in the market,” said Joe Onofrio, Partner at Five Elms Capital. “Our investment in Scilife underscores our belief in their vision to embed quality into the DNA of every organization. We are excited to support Scilife in its next phase of growth and innovation.”
Interested to know about other companies that got investments from reputed companies? Then please visit:
Bionova Scientific announces USD 100 mln investment in new Plasmid DNA facility
AST SpaceMobile Receives Investment From AT&T, Google and Vodafone
